Evidence that the angiotensin IV (AT(4)) receptor is the enzyme insulin-regulated aminopeptidase
Details
Publication Year 2001-12-28,Volume 276,Issue #52,Page 48623-48626
Journal Title
JOURNAL OF BIOLOGICAL CHEMISTRY
Publication Type
Journal Article
Abstract
Central infusion of angiotensin IV or its more stable analogues facilitates memory retention and retrieval in normal animals and reverses amnesia induced by scopolamine or by bilateral perforant pathway lesions. These peptides bind with high affinity and specificity to a novel binding site designated the angiotensin AT(4) receptor. Until now, the AT(4) receptor has eluded molecular characterization. Here we identify the AT(4) receptor, by protein purification and peptide sequencing, to be insulin-regulated aminopeptidase (IRAP). HEK 293T cells transfected with IRAP exhibit typical AT(4) receptor binding characteristics; the AT(4) receptor ligands, angiotensin IV and LVV-hemorphin 7, compete for the binding of [I-125]Nle(1)-angiotensin IV with IC50 values of 32 and 140 nM, respectively. The distribution of IRAP and its mRNA in the brain, determined by immunohistochemistry and hybridization histochemistry, parallels that of the AT(4) receptor determined by radioligand binding. We also show that AT(4) receptor ligands dose-dependently inhibit the catalytic activity of IRAP. We have therefore demonstrated that the AT(4) receptor is IRAP and propose that AT(4) receptor ligands may exert their effects by inhibiting the catalytic activity of IRAP thereby extending the half-life of its neuropeptide substrates.
Publisher
AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC
Keywords
MEMBRANE AMINOPEPTIDASE; BRAIN; MEMORY; GLUT4; BINDING; SYSTEM; LOCALIZATION; CELLS; RATS
Terms of Use/Rights Notice
Refer to copyright notice on published article.


Creation Date: 2001-12-28 12:00:00
An error has occurred. This application may no longer respond until reloaded. Reload 🗙